Target intelligence / Profile preview

SPEN antisense RNA 1 (SPEN-AS1)

Target
SPEN-AS1
Molecular classification
Other (long non-coding RNA)
01

Overview

SPEN antisense RNA 1 (SPEN-AS1) is a long non-coding RNA transcribed from the antisense strand of the SPEN gene locus. Unlike the SPEN protein (which encodes a large transcriptional repressor with critical roles in gene regulation, X-chromosome inactivation, and development[1][2][3]), SPEN-AS1 does not encode a protein, and its biological role remains poorly defined. It belongs to the molecular class of long non-coding RNAs, which may play regulatory functions in gene expression, but no specific or direct interactions, disease roles, or therapeutic applications have been described in the available literature[4]. Most research and discussion surrounding the SPEN locus focus on the protein-coding SPEN gene and the SPEN protein rather than its antisense RNA transcript. If "SPEN-AS1" was intended to refer to the protein-coding gene or protein (known as SPEN, SHARP, or MINT), please clarify, as the protein has established biological significance and disease relevance[1][2][3]. Note: If your intent was the protein (SHARP/SPEN), it would be classified as a transcriptional corepressor with major functions in gene silencing, nuclear receptor regulation, and Xist-mediated X chromosome inactivation, and is implicated in cancer and developmental biology[1][2][3].

Other names
FLJ37453SPEN-AS1
02

Mechanism of action

Not established for SPEN-AS1; no therapeutic targeting mechanisms described.

03

Biological functions

Gene regulation (inferred for the lncRNA class)Additional specific functions for SPEN-AS1 are not well characterized in literature available from search results.
04

Disease associations

Other (there is no strongly established disease association for SPEN-AS1 itself in the major literature; most literature refers to the SPEN protein, not the antisense RNA[1][2][3])

Beyond the preview

Go deeper on SPEN antisense RNA 1 (SPEN-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPEN antisense RNA 1 (SPEN-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call